Exchange: NYSE·Updated 04:28 PM EST
GKOS logo

GKOS Glaukos Corporation

$237.31
$0.79
(0.33%)
Today
Closed $237.31
$0.00
(0.00%)
After Hours
Reported EarningsOct 28
Mkt Cap$14.09B
Vol1.08M

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard A. Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
41

Bearish Sentiment

How do you feel about GKOS?

Advertisement|Remove ads.